These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9808202)

  • 1. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis.
    Wallström E; Khademi M; Andersson M; Weissert R; Linington C; Olsson T
    Eur J Immunol; 1998 Oct; 28(10):3329-35. PubMed ID: 9808202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosis.
    Zhang X; Tang Y; Sujkowska D; Wang J; Ramgolam V; Sospedra M; Adams J; Martin R; Pinilla C; Markovic-Plese S
    Eur J Immunol; 2008 May; 38(5):1297-309. PubMed ID: 18412170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis.
    Khare M; Rodriguez M; David CS
    Int Immunol; 2003 Apr; 15(4):535-46. PubMed ID: 12663683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
    Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
    Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice.
    Kort JJ; Kawamura K; Fugger L; Weissert R; Forsthuber TG
    J Neuroimmunol; 2006 Apr; 173(1-2):23-34. PubMed ID: 16386804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
    Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
    J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls.
    Van der Aa A; Hellings N; Bernard CC; Raus J; Stinissen P
    J Neuroimmunol; 2003 Apr; 137(1-2):164-76. PubMed ID: 12667661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein.
    Lindert RB; Haase CG; Brehm U; Linington C; Wekerle H; Hohlfeld R
    Brain; 1999 Nov; 122 ( Pt 11)():2089-100. PubMed ID: 10545394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.
    Weissert R; Kuhle J; de Graaf KL; Wienhold W; Herrmann MM; Müller C; Forsthuber TG; Wiesmüller KH; Melms A
    J Immunol; 2002 Jul; 169(1):548-56. PubMed ID: 12077287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin basic protein and myelin oligodendrocyte glycoprotein T-cell repertoire in childhood and juvenile multiple sclerosis.
    Correale J; Tenembaum SN
    Mult Scler; 2006 Aug; 12(4):412-20. PubMed ID: 16900754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
    Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P
    J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoreactivity to myelin antigens related to HLA associations with multiple sclerosis.
    Yentür SP; Akman-Demir G; Eraksoy M; Saruhan-Direskeneli G
    Mult Scler; 2002 Aug; 8(4):278-83. PubMed ID: 12166496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype.
    Dhib-Jalbut S; Chen M; Said A; Zhan M; Johnson KP; Martin R
    J Neuroimmunol; 2003 Jul; 140(1-2):163-71. PubMed ID: 12864985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
    Kerlero de Rosbo N; Hoffman M; Mendel I; Yust I; Kaye J; Bakimer R; Flechter S; Abramsky O; Milo R; Karni A; Ben-Nun A
    Eur J Immunol; 1997 Nov; 27(11):3059-69. PubMed ID: 9394837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen.
    Diaz-Villoslada P; Shih A; Shao L; Genain CP; Hauser SL
    J Neuroimmunol; 1999 Sep; 99(1):36-43. PubMed ID: 10496175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
    Weissert R; de Graaf KL; Storch MK; Barth S; Linington C; Lassmann H; Olsson T
    J Immunol; 2001 Jun; 166(12):7588-99. PubMed ID: 11390515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides.
    Ichikawa M; Johns TG; Adelmann M; Bernard CC
    Int Immunol; 1996 Nov; 8(11):1667-74. PubMed ID: 8943561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis.
    Raddassi K; Kent SC; Yang J; Bourcier K; Bradshaw EM; Seyfert-Margolis V; Nepom GT; Kwok WW; Hafler DA
    J Immunol; 2011 Jul; 187(2):1039-46. PubMed ID: 21653833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human T cell response to myelin oligodendrocyte glycoprotein: a multiple sclerosis family-based study.
    Koehler NK; Genain CP; Giesser B; Hauser SL
    J Immunol; 2002 Jun; 168(11):5920-7. PubMed ID: 12023398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.